These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38640229)

  • 1. GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma.
    Wang D; Mahmud I; Thakur VS; Tan SK; Isom DG; Lombard DB; Gonzalgo ML; Kryvenko ON; Lorenzi PL; Tcheuyap VT; Brugarolas J; Welford SM
    Cancer Res; 2024 Jul; 84(13):2141-2154. PubMed ID: 38640229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemerin causes lipid metabolic imbalance and induces passive lipid accumulation in human hepatoma cell line via the receptor GPR1.
    Zhu L; Huang J; Wang Y; Yang Z; Chen X
    Life Sci; 2021 Aug; 278():119530. PubMed ID: 33887347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
    Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
    Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.
    Qiu B; Ackerman D; Sanchez DJ; Li B; Ochocki JD; Grazioli A; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC
    Cancer Discov; 2015 Jun; 5(6):652-67. PubMed ID: 25829424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SREBP1-driven lipid desaturation supports clear cell renal cell carcinoma growth through regulation of NF-κB signaling.
    Yang H; Zhang X; Liu F; Fan J; Wang B; Dong C
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1383-1388. PubMed ID: 29183723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell Carcinoma.
    Riscal R; Gardner SM; Coffey NJ; Carens M; Mesaros C; Xu JP; Xue Y; Davis L; Demczyszyn S; Vogt A; Olia A; Finan JM; Godfrey J; Schultz DC; Blair IA; Keith B; Marmorstein R; Skuli N; Simon MC
    Cancer Res; 2024 May; 84(10):1570-1582. PubMed ID: 38417134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARγ is dispensable for clear cell renal cell carcinoma progression.
    Sanchez DJ; Steger DJ; Skuli N; Bansal A; Simon MC
    Mol Metab; 2018 Aug; 14():139-149. PubMed ID: 29866440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
    Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMKLR1 and GPR1 mediate chemerin signaling through the RhoA/ROCK pathway.
    Rourke JL; Dranse HJ; Sinal CJ
    Mol Cell Endocrinol; 2015 Dec; 417():36-51. PubMed ID: 26363224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
    Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
    Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance.
    Tan SK; Mahmud I; Fontanesi F; Puchowicz M; Neumann CKA; Griswold AJ; Patel R; Dispagna M; Ahmed HH; Gonzalgo ML; Brown JM; Garrett TJ; Welford SM
    Cancer Discov; 2021 Aug; 11(8):2072-2093. PubMed ID: 33757970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
    Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
    Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.
    Syafruddin SE; Rodrigues P; Vojtasova E; Patel SA; Zaini MN; Burge J; Warren AY; Stewart GD; Eisen T; Bihary D; Samarajiwa SA; Vanharanta S
    Nat Commun; 2019 Mar; 10(1):1152. PubMed ID: 30858363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABPA inhibits tumorigenesis in clear cell renal cell carcinoma by regulating ferroptosis through ACSL4.
    Wu Y; Wu Z; Yao M; Liu L; Song Y; Ma L; Liu C
    Sci Rep; 2024 Nov; 14(1):26521. PubMed ID: 39489850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEC14L3 knockdown inhibited clear cell renal cell carcinoma proliferation, metastasis and sunitinib resistance through an SEC14L3/RPS3/NFκB positive feedback loop.
    Jiang Z; Yang G; Wang G; Wan J; Zhang Y; Song W; Zhang H; Ni J; Zhang H; Luo M; Wang K; Peng B
    J Exp Clin Cancer Res; 2024 Oct; 43(1):288. PubMed ID: 39425205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.